TD Asset Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-12,352
| Closed | -$14K | – | 1465 |
|
2018
Q2 | $14K | Sell |
12,352
-38,041
| -75% | -$43.1K | ﹤0.01% | 1410 |
|
2018
Q1 | $101K | Buy |
+50,393
| New | +$101K | ﹤0.01% | 1332 |
|
2016
Q4 | – | Sell |
-36,500
| Closed | -$203K | – | 1415 |
|
2016
Q3 | $203K | Hold |
36,500
| – | – | ﹤0.01% | 1369 |
|
2016
Q2 | $203K | Hold |
36,500
| – | – | ﹤0.01% | 1321 |
|
2016
Q1 | $161K | Hold |
36,500
| – | – | ﹤0.01% | 1325 |
|
2015
Q4 | $220K | Buy |
+36,500
| New | +$220K | ﹤0.01% | 1293 |
|